Gonzalez Joshua R, Consedine Nathan S, McKiernan James M, Spencer Benjamin A
Department of Urology, Columbia University, New York, New York, USA.
J Urol. 2008 Dec;180(6):2403-8; discussion 2408. doi: 10.1016/j.juro.2008.08.031. Epub 2008 Oct 18.
Black American and Afro-Caribbean men may experience the highest incidence of prostate cancer globally. We examined the effect of race/ethnicity on the initiation and maintenance of annual prostate specific antigen screening and the role of physicians in screening continuity in these high risk groups.
Stratified cluster sampling of census tract blocks in Brooklyn, New York yielded 533 male participants 45 to 70 years old. The men were classified into 4 racial/ethnic groups, including white men born in the United States, black men born in the United States, immigrant Jamaican men, and immigrant men from Trinidad and Tobago. Participants recorded the number of prostate specific antigen tests performed in the last 10 years. Subject adherence was calculated as annually screened, less than annually screened and never screened. Multinomial logistic regression was used to compare screening behavior across the ethnic groups.
Overall 28.3% of participants reported annual screening, 44.5% reported screening less than annually and 27.2% reported having never been screened. Jamaicans (OR 3.1) and men from Trinidad and Tobago (OR 5.4) were more likely to screen less than annually compared to not at all. However, black American men (OR 0.3), Jamaican men (OR 0.3), and men from Trinidad and Tobago (OR 0.2) were less likely to maintain annual screening compared with white men, as were men who did not undergo an annual physical examination (OR 0.3) and those with low prostate cancer knowledge (0.5).
Afro-Caribbean men are not less likely than white men to undergo initial prostate specific antigen screening but they are much less likely to maintain annual screening. Through comprehensive discussion and annual examinations physicians have an important role in ensuring prostate specific antigen screening continuity. Our results suggest the need for more culturally appropriate outreach efforts and educational interventions to improve screening compliance.
美国黑人男性和非洲裔加勒比男性可能是全球前列腺癌发病率最高的人群。我们研究了种族/族裔对年度前列腺特异性抗原筛查的启动和持续进行的影响,以及医生在这些高危人群筛查连续性中的作用。
对纽约布鲁克林的人口普查街区进行分层整群抽样,选取了533名45至70岁的男性参与者。这些男性被分为4个种族/族裔组,包括在美国出生的白人男性、在美国出生的黑人男性、牙买加移民男性以及来自特立尼达和多巴哥的移民男性。参与者记录了过去10年中进行前列腺特异性抗原检测的次数。将受试者的依从性分为每年接受筛查、筛查频率低于每年一次以及从未接受筛查。采用多项逻辑回归比较各民族群体的筛查行为。
总体而言,28.3%的参与者报告每年进行筛查,44.5%的参与者报告筛查频率低于每年一次,27.2%的参与者报告从未接受过筛查。与完全不筛查相比,牙买加人(比值比3.1)和来自特立尼达和多巴哥的男性(比值比5.4)更有可能筛查频率低于每年一次。然而,与白人男性相比,美国黑人男性(比值比0.3)、牙买加男性(比值比0.3)以及来自特立尼达和多巴哥的男性(比值比0.2)保持每年筛查的可能性较小,未进行年度体检的男性(比值比0.3)以及前列腺癌知识水平较低的男性(比值比0.5)也是如此。
非洲裔加勒比男性进行初始前列腺特异性抗原筛查的可能性并不低于白人男性,但他们保持每年筛查的可能性要小得多。通过全面的讨论和年度检查,医生在确保前列腺特异性抗原筛查的连续性方面发挥着重要作用。我们的结果表明,需要开展更多符合文化背景的外展工作和教育干预措施,以提高筛查的依从性。